TRACE
Trace a source
tape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advicetape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advice
publisheddirectional thesisLONGyoutubenot an explicit trade

ANTHROPIC directional thesis

Every model rejection is a sales funnel, blocking biohackers and rivals isn't really safety, it's a hard-nosed move to push paying users onto pricey enterprise plans where the real money sits.

$1,700entry snapshot
pendingcurrent snapshot
— pendingsince mention
“this aligns with Anthropic's focus on safety. But as many people have pointed out, it's also just good business. You don't want competitors using your products to directly create competitors.”
19:43claim_id mcl_9b912a4a7c751784b7open evidence ↗
Classification directional thesis

Human-reviewed public claim.

Evidence span 19:43

Evidence URL, source timestamp, and excerpt are attached to this permanent claim page.

Correction path available

Creators or reviewers can request reclassification, context, or entity corrections without erasing the source record.

Machine-readable claim
{
  "version": "market-claims.v1",
  "claim": {
    "id": "mcl_9b912a4a7c751784b7",
    "url": "/trace/claims/mcl_9b912a4a7c751784b7",
    "status": "PUBLISHED",
    "claimType": "DIRECTIONAL_THESIS",
    "direction": "LONG",
    "claimText": "Every model rejection is a sales funnel, blocking biohackers and rivals isn't really safety, it's a hard-nosed move to push paying users onto pricey enterprise plans where the real money sits.",
    "confidence": 0.72,
    "expert": {
      "slug": "johncoogan",
      "displayName": "John Coogan",
      "kind": "PERSON",
      "status": "UNCLAIMED",
      "avatarUrl": "/api/avatars/0cda18e2-3",
      "url": "/trace/experts/johncoogan",
      "claimed": false
    },
    "primaryEntity": {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "ANTHROPIC",
      "name": "ANTHROPIC",
      "exchange": null,
      "confidence": 0.78
    },
    "evidence": {
      "evidenceUrl": "https://www.youtube.com/watch?v=Rb_SENf-pEQ&t=1183s",
      "sourceUrl": "https://youtube.com/watch?v=Rb_SENf-pEQ",
      "timecode": "19:43",
      "startMs": 1183000,
      "endMs": null,
      "excerpt": "this aligns with Anthropic's focus on safety. But as many people have pointed out, it's also just good business. You don't want competitors using your products to directly create competitors."
    },
    "performance": {
      "entryPrice": 1700,
      "currentPrice": null,
      "returnPct": null,
      "relativePct": null,
      "method": "PASTE_AUTHOR_PRICE"
    },
    "resolutionStatus": "OPEN",
    "ambiguityNotes": null,
    "horizon": "multi-year",
    "isExplicitTrade": false,
    "notFinancialAdvice": true,
    "disclaimer": "AISO tracks public statements, not verified portfolio positions. This is not financial advice."
  },
  "expert": {
    "slug": "johncoogan",
    "displayName": "John Coogan",
    "kind": "PERSON",
    "status": "UNCLAIMED",
    "avatarUrl": "/api/avatars/0cda18e2-3",
    "url": "/trace/experts/johncoogan",
    "claimed": false
  },
  "source": {
    "platform": "YOUTUBE",
    "title": "Facebook gets a movie, Anthropic gets a Fable, Vinod Khosla, Matthew Prince, Bret Taylor",
    "sourceUrl": "https://youtube.com/watch?v=Rb_SENf-pEQ",
    "publishedAt": "2026-06-10T18:22:14.000Z"
  },
  "evidence": {
    "evidenceUrl": "https://www.youtube.com/watch?v=Rb_SENf-pEQ&t=1183s",
    "sourceUrl": "https://youtube.com/watch?v=Rb_SENf-pEQ",
    "timecode": "19:43",
    "startMs": 1183000,
    "endMs": null,
    "excerpt": "this aligns with Anthropic's focus on safety. But as many people have pointed out, it's also just good business. You don't want competitors using your products to directly create competitors.",
    "quote": "this aligns with Anthropic's focus on safety. But as many people have pointed out, it's also just good business. You don't want competitors using your products to directly create competitors.",
    "speaker": "John Coogan"
  },
  "entities": [
    {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "ANTHROPIC",
      "name": "ANTHROPIC",
      "exchange": null,
      "confidence": 0.78
    }
  ],
  "marketData": {
    "entry": {
      "price": 1700,
      "currency": "USD",
      "observedAt": "2026-06-10T18:22:14.000Z",
      "method": "PASTE_AUTHOR_PRICE"
    },
    "current": null,
    "returnPct": null
  },
  "snapshots": [
    {
      "kind": "ENTRY",
      "symbol": "ANTHROPIC",
      "assetClass": "EQUITY",
      "price": 1700,
      "probability": null,
      "currency": "USD",
      "provider": "paste.trade",
      "providerSymbol": "vntl:ANTHROPIC",
      "observedAt": "2026-06-10T18:22:14.000Z",
      "method": "PASTE_AUTHOR_PRICE",
      "returnPct": null,
      "relativePct": null
    }
  ]
}

AISO Market Calls classifies public statements from public sources. A classification such as long thesis, short thesis, or explicit call describes the content of the public statement and does not prove that the speaker actually entered, exited, or held a position. Market performance shown is calculated from public market data around the source publication or timestamp. It is not investment advice.